guest ::
| Home > Publications database > ADAR RNA editing on antisense RNAs results in apparent U-to-C base changes on overlapping sense transcripts. > print |
| Home > Publications database > ADAR RNA editing on antisense RNAs results in apparent U-to-C base changes on overlapping sense transcripts. > print |
| 001 | 212490 | ||
| 005 | 20240229154912.0 | ||
| 024 | 7 | _ | |a 10.3389/fcell.2022.1080626 |2 doi |
| 024 | 7 | _ | |a pmid:36684421 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC9852825 |2 pmc |
| 024 | 7 | _ | |a altmetric:140915811 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2023-00191 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |a Pecori, Riccardo |0 P:(DE-He78)a8b399fa71eacddc353846ca1d9d2127 |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a ADAR RNA editing on antisense RNAs results in apparent U-to-C base changes on overlapping sense transcripts. |
| 260 | _ | _ | |a Lausanne |c 2023 |b Frontiers Media |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1698997917_23208 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:D150#LA:D150# / HI-TRON |
| 520 | _ | _ | |a Despite hundreds of RNA modifications described to date, only RNA editing results in a change in the nucleotide sequence of RNA molecules compared to the genome. In mammals, two kinds of RNA editing have been described so far, adenosine to inosine (A-to-I) and cytidine to uridine (C-to-U) editing. Recent improvements in RNA sequencing technologies have led to the discovery of a continuously growing number of editing sites. These methods are powerful but not error-free, making routine validation of newly-described editing sites necessary. During one of these validations on DDX58 mRNA, along with A-to-I RNA editing sites, we encountered putative U-to-C editing. These U-to-C edits were present in several cell lines and appeared regulated in response to specific environmental stimuli. The same findings were also observed for the human long intergenic non-coding RNA p21 (hLincRNA-p21). A more in-depth analysis revealed that putative U-to-C edits result from A-to-I editing on overlapping antisense RNAs that are transcribed from the same loci. Such editing events, occurring on overlapping genes transcribed in opposite directions, have recently been demonstrated to be immunogenic and have been linked with autoimmune and immune-related diseases. Our findings, also confirmed by deep transcriptome data, demonstrate that such loci can be recognized simply through the presence of A-to-I and U-to-C mismatches within the same locus, reflective A-to-I editing both in the sense-oriented transcript and in the cis-natural antisense transcript (cis-NAT), implying that such clusters could be a mark of functionally relevant ADAR1 editing events. |
| 536 | _ | _ | |a 314 - Immunologie und Krebs (POF4-314) |0 G:(DE-HGF)POF4-314 |c POF4-314 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a ADAR |2 Other |
| 650 | _ | 7 | |a DDX58/RIG-I |2 Other |
| 650 | _ | 7 | |a LINC-P21 |2 Other |
| 650 | _ | 7 | |a MultiEditR |2 Other |
| 650 | _ | 7 | |a RNA editing |2 Other |
| 650 | _ | 7 | |a U-to-C |2 Other |
| 700 | 1 | _ | |a Chillón, Isabel |b 1 |
| 700 | 1 | _ | |a Lo Giudice, Claudio |b 2 |
| 700 | 1 | _ | |a Arnold, Annette |0 P:(DE-He78)7c776439971ef21f36ac730cfbff7fff |b 3 |u dkfz |
| 700 | 1 | _ | |a Wüst, Sandra |0 P:(DE-He78)06a6077b0cfcb0f4890fb5f2543c43be |b 4 |u dkfz |
| 700 | 1 | _ | |a Binder, Marco |0 P:(DE-He78)2fb2bd9048a3777dddc4cb89b115c187 |b 5 |u dkfz |
| 700 | 1 | _ | |a Marcia, Marco |b 6 |
| 700 | 1 | _ | |a Picardi, Ernesto |b 7 |
| 700 | 1 | _ | |a Papavasiliou, Fotini |0 P:(DE-He78)79dbda58d51b613a0a421f579d2dfed3 |b 8 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.3389/fcell.2022.1080626 |g Vol. 10, p. 1080626 |0 PERI:(DE-600)2737824-X |p 1080626 |t Frontiers in cell and developmental biology |v 10 |y 2023 |x 2296-634X |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:212490 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)a8b399fa71eacddc353846ca1d9d2127 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)7c776439971ef21f36ac730cfbff7fff |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)06a6077b0cfcb0f4890fb5f2543c43be |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)2fb2bd9048a3777dddc4cb89b115c187 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)79dbda58d51b613a0a421f579d2dfed3 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-314 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Immunologie und Krebs |x 0 |
| 914 | 1 | _ | |y 2023 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2021-05-13T10:29:32Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2021-05-13T10:29:32Z |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2021-05-13T10:29:32Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2022-11-12 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-12 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2022-11-12 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2022-11-12 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b FRONT CELL DEV BIOL : 2022 |d 2023-10-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-26 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2021-05-13T10:29:32Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-26 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b FRONT CELL DEV BIOL : 2022 |d 2023-10-26 |
| 920 | 2 | _ | |0 I:(DE-He78)D150-20160331 |k D150 |l D150 Immundiversität |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)D150-20160331 |k D150 |l D150 Immundiversität |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)F170-20160331 |k F170 |l F170 Virus-assoziierte Karzinogenese |x 1 |
| 920 | 0 | _ | |0 I:(DE-He78)D150-20160331 |k D150 |l D150 Immundiversität |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)D150-20160331 |
| 980 | _ | _ | |a I:(DE-He78)F170-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|